Market Data & Analytics has launched “insightMED”, an information service that delivers expert assessments and opinions on potentially market-moving news relating to the pharmaceutical industry. Developed in cooperation with market participants, insightMED provides investors, analysts and industry experts who are active in the pharmaceutical sector with trading-relevant information on approximately 100 global pharmaceutical companies.
insightMED is based on pharmaceutical news surveys conducted by Deutsche Boerse and administered to physicians within an independent online platform called coliquio. The responses are collected, analysed and aggregated into a consolidated report, which is then disseminated to vendors and end users in real time. The survey results and insightMED reports illustrate the importance of selected news items for the medical community and allow market participants to make trading and investment decisions. An example of an insightMED report is the physicians’ opinions on the sales potential of a new prescription drug, which in turn can impact the stock price of the drugmaker. insightMED therefore can serve as a useful decision making tool for investors trading in pharmaceutical stocks.
“insightMED gives traders, analysts and portfolio managers unique access to the expertise of roughly 42,000 physicians in Europe. The news is evaluated within a very short time period and the results are provided in a concise, easily accessible format”, said Georg Gross, Head of Front Office Data & Analytics at Deutsche Börse. “insightMED provides professional knowledge from a group of experts, but also clear, meaningful information that has been edited for consumption by a broader audience.”
insightMED is available via the real-time direct data feed CEF Core; reports can also be downloaded from atwww.insightmed-interactive.com
The physicians’ platform coliquio was formed in 2007. More than 42,000 licensed and practising physicians from all over Europe use coliquio to share their experiences and medical knowledge. The expertise of this community of medical professionals is now systematically made available to the capital markets.
About Deutsche Börse Market Data & Analytics
Deutsche Börse is one of the world’s leading service providers for the securities industry with a product and service offering for issuers, investors, intermediaries and data vendors. The Group covers the entire process chain from trading, through clearing, to settlement and securities custody. Deutsche Börse Market Data & Analytics collects, refines and disseminates capital market-relevant data. The product range includes price data, trading statistics, analyses, master data and approximately 3,400 indices which document what is happening on the international financial markets and make it transparent.